Literature DB >> 22922916

Somatoform abdominal pain in surgery: is SD worthy of surgical attention? Case reports and literature review.

Sami Medani Abd Elwahab1, Eva Doherty, Hashim Elsheikh.   

Abstract

Somatoform disorders (SD) or medically unexplained physical symptoms (MUPS) are a group of disorders that represent a group of symptoms that cannot be explained by an organic or physical pathology. These disorders are widely prevalent, and, if unrecognised, SD may lead medical professionals to embark on tests or procedures which may inflict unnecessary iatrogenic complications. Despite the high prevalence, they are only poorly included in medical training curricula, at both undergraduate and postgraduate levels. In this article, we review the literature and present two cases. The first one presented with a recurrent acute abdomen had an unnecessary CT abdomen. The second case had laparoscopy for acute right-sided abdominal pain which turned out to be normal, and was readmitted again after a short period with acute urine retention which resolved spontaneously following discussion with the patient and family. Both cases were referred for psychiatric assessment and their family doctors were informed.

Entities:  

Mesh:

Year:  2012        PMID: 22922916      PMCID: PMC4543361          DOI: 10.1136/bcr-2012-006306

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  [Psychopathological aspects of pain syndrome in somatoform disorders].

Authors:  N N Petrova
Journal:  Klin Med (Mosk)       Date:  2002

2.  Specific somatoform disorder in the general population.

Authors:  Hans Joergen Grabe; Christian Meyer; Ulfert Hapke; Hans-Juergen Rumpf; Harald Juergen Freyberger; Horst Dilling; Ulrich John
Journal:  Psychosomatics       Date:  2003 Jul-Aug       Impact factor: 2.386

3.  Presentation of the Multidisciplinary Guideline Medically Unexplained Physical Symptoms (MUPS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles.

Authors:  Christina M van der Feltz-Cornelis; Rob Hoedeman; Emile J W Keuter; Jan A Swinkels
Journal:  J Psychosom Res       Date:  2011-12-09       Impact factor: 3.006

4.  Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care.

Authors:  K Kroenke; R L Spitzer; F V deGruy; S R Hahn; M Linzer; J B Williams; D Brody; M Davies
Journal:  Arch Gen Psychiatry       Date:  1997-04

5.  The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study.

Authors:  Roselind Lieb; Petra Zimmermann; Robert H Friis; Michael Höfler; Sven Tholen; Hans Ulrich Wittchen
Journal:  Eur Psychiatry       Date:  2002-10       Impact factor: 5.361

6.  [Unexplained physical symptoms: a widespread problem but still low-profile in training programs and guidelines].

Authors:  R C van der Mast
Journal:  Ned Tijdschr Geneeskd       Date:  2006-03-25

7.  Factors leading to the reporting of 'functional' somatic symptoms by general practice attenders.

Authors:  D B Mumford; T A Devereux; P J Maddy; J V Johnston
Journal:  Br J Gen Pract       Date:  1991-11       Impact factor: 5.386

8.  Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders.

Authors:  Kari Ann Leiknes; Arnstein Finset; Torbjørn Moum; Inger Sandanger
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

9.  Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders.

Authors:  Margot W M de Waal; Ingrid A Arnold; Just A H Eekhof; Albert M van Hemert
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

Review 10.  Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS).

Authors:  Christopher Burton
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.